Free Trial

Envista (NVST) Competitors

Envista logo
$15.63 +0.17 (+1.10%)
As of 04/14/2025 03:58 PM Eastern

NVST vs. PEN, STVN, GKOS, NARI, INSP, BLCO, SLNO, IRTC, PRCT, and TMDX

Should you be buying Envista stock or one of its competitors? The main competitors of Envista include Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), Inspire Medical Systems (INSP), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), PROCEPT BioRobotics (PRCT), and TransMedics Group (TMDX). These companies are all part of the "medical equipment" industry.

Envista vs.

Envista (NYSE:NVST) and Penumbra (NYSE:PEN) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, community ranking, earnings, analyst recommendations, valuation, risk, media sentiment and dividends.

In the previous week, Envista had 1 more articles in the media than Penumbra. MarketBeat recorded 16 mentions for Envista and 15 mentions for Penumbra. Penumbra's average media sentiment score of 0.60 beat Envista's score of 0.53 indicating that Penumbra is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Envista
5 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Positive
Penumbra
5 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Positive

Penumbra has a net margin of 1.17% compared to Envista's net margin of -44.56%. Penumbra's return on equity of 9.74% beat Envista's return on equity.

Company Net Margins Return on Equity Return on Assets
Envista-44.56% 3.86% 2.21%
Penumbra 1.17%9.74%7.35%

Penumbra received 797 more outperform votes than Envista when rated by MarketBeat users. Likewise, 80.29% of users gave Penumbra an outperform vote while only 33.33% of users gave Envista an outperform vote.

CompanyUnderperformOutperform
EnvistaOutperform Votes
34
33.33%
Underperform Votes
68
66.67%
PenumbraOutperform Votes
831
80.29%
Underperform Votes
204
19.71%

Envista has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500. Comparatively, Penumbra has a beta of 0.56, suggesting that its share price is 44% less volatile than the S&P 500.

Envista presently has a consensus target price of $20.18, indicating a potential upside of 29.10%. Penumbra has a consensus target price of $293.80, indicating a potential upside of 8.50%. Given Envista's higher possible upside, research analysts plainly believe Envista is more favorable than Penumbra.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envista
2 Sell rating(s)
10 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.07
Penumbra
0 Sell rating(s)
3 Hold rating(s)
13 Buy rating(s)
1 Strong Buy rating(s)
2.88

88.9% of Penumbra shares are held by institutional investors. 1.3% of Envista shares are held by insiders. Comparatively, 5.0% of Penumbra shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Penumbra has lower revenue, but higher earnings than Envista. Envista is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envista$2.51B1.07-$1.12B-$6.49-2.41
Penumbra$1.19B8.77$90.95M$0.34796.41

Summary

Penumbra beats Envista on 15 of the 19 factors compared between the two stocks.

Remove Ads
Get Envista News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVST and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NVST vs. The Competition

MetricEnvistaDental equipment & supplies IndustryMedical SectorNYSE Exchange
Market Cap$2.69B$3.74B$5.35B$18.51B
Dividend YieldN/A2.65%5.11%4.25%
P/E Ratio-2.4141.7921.7531.06
Price / Sales1.071.39380.5126.47
Price / Cash12.916.5738.1517.54
Price / Book0.920.606.434.29
Net Income-$1.12B-$153.72M$3.20B$1.02B
7 Day Performance6.15%2.97%9.08%6.72%
1 Month Performance-5.99%-16.43%-6.04%-6.79%
1 Year Performance-18.42%-36.29%10.66%1.22%

Envista Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NVST
Envista
4.3947 of 5 stars
$15.63
+1.1%
$20.18
+29.1%
-18.5%$2.69B$2.51B-2.4112,700Analyst Revision
Gap Up
PEN
Penumbra
3.8568 of 5 stars
$263.59
+0.5%
$294.47
+11.7%
+24.5%$10.15B$1.19B775.253,900Short Interest ↑
Gap Up
STVN
Stevanato Group
1.7165 of 5 stars
€19.23
+1.1%
N/A-24.1%$5.82B$1.10B40.914,650Positive News
GKOS
Glaukos
4.5779 of 5 stars
$85.87
+2.7%
$163.25
+90.1%
-5.3%$4.86B$383.48M-29.92780Gap Up
High Trading Volume
NARI
Inari Medical
0.3514 of 5 stars
$79.97
flat
$68.00
-15.0%
N/A$4.68B$493.63M-59.24800
INSP
Inspire Medical Systems
4.6412 of 5 stars
$149.72
+5.5%
$226.70
+51.4%
-35.4%$4.46B$802.80M86.541,246Positive News
Gap Down
BLCO
Bausch + Lomb
3.9812 of 5 stars
$11.86
-2.1%
$18.82
+58.7%
-14.0%$4.18B$4.79B-13.0312,500Gap Down
SLNO
Soleno Therapeutics
4.7936 of 5 stars
$69.64
+3.2%
$99.63
+43.1%
+88.5%$3.19BN/A-20.9830Analyst Forecast
Positive News
High Trading Volume
IRTC
iRhythm Technologies
0.9164 of 5 stars
$100.17
-0.2%
$119.73
+19.5%
-8.8%$3.15B$591.84M-27.521,790Positive News
PRCT
PROCEPT BioRobotics
2.3789 of 5 stars
$50.83
-0.8%
$94.29
+85.5%
+6.0%$2.79B$224.50M-26.07430Positive News
Gap Down
High Trading Volume
TMDX
TransMedics Group
2.7537 of 5 stars
$69.15
+2.2%
$122.70
+77.4%
-5.4%$2.33B$441.54M73.56210Gap Up
Remove Ads

Related Companies and Tools


This page (NYSE:NVST) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners